GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Tonix Pharmaceuticals Holding TNXP · USD

Health Care · US listing · 🇺🇸 United States

Compare

4.49

-5.27%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Tonix Pharmaceuticals Holding

Our reporting

Next results

9 Nov 2026

Due on 9 Nov 2026. Analysts expect earnings of -2.39 a share on revenue of $16.3m.

Past results

Reported against what analysts expected

10 Aug 202611 May 202612 Mar 202610 Nov 202512 Aug 202518 Mar 2025
Earnings per share-2.44-2.93-3.98-3.59-3.86-9.77
Forecast-2.64-2.54-3.16-3.59-3.10-6.23
Revenue$13.5m$6.9m$5.4m$3.3m$2.0m$2.6m
Forecast$7.7m$6.1m$3.0m$2.3m$2.4m$3.2m

Key events

  1. 5 Feb 2025100-to-1 reverse split
  2. 10 Jun 202432-to-1 reverse split
  3. 10 May 20236.25-to-1 reverse split
  4. 17 May 202232-to-1 reverse split
  5. 1 Nov 201910-to-1 reverse split
  6. 28 Nov 201810-to-1 reverse split

Tonix Pharmaceuticals Holding in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.